Wide Ranks

BLFS

BioLife Solutions, Inc.

27.16

Top Statistics
Market Cap 1 B Forward PE -502.96 Revenue Growth 29.70 %
Current Ratio 2.78 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -31.32 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -45.17 Enterprise / Revenue 8.61 Price To Sales Trailing12 Months 8.57
Profitability
Profit Margins -31.32 % Operating Margins -5.10 %
Balance Sheet
Total Cash 34 M Total Cash Per Share 0.7370 Total Debt 39 M
Total Debt To Equity 12.06 Current Ratio 2.78 Book Value Per Share 7.04
All Measures
Short Ratio 639.00 % Message Board Id finmb_265126 Fax 425 402 1433
Shares Short Prior Month 3 M Return On Equity -0.1504 City Bothell
Uuid 58d7872b-3526-33db-9a35-a3add74a3117 Previous Close 27.06 First Trade Date Epoch Utc 627 M
Book Value 7.04 Beta 1.88 Total Debt 39 M
Volume 283255 Price To Book 3.86 Last Split Date 1 B
Fifty Two Week Low 11.91 Total Cash Per Share 0.7370 Total Revenue 146 M
Shares Short Previous Month Date 1 B Target Median Price 30.00 Audit Risk 10
Max Age 86400 Recommendation Mean 1.20 Sand P52 Week Change 0.3133
Operating Margins -5.10 % Target Mean Price 29.80 Net Income To Common -49445000
Short Percent Of Float 0.0855 Implied Shares Outstanding 46 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 705950 Average Volume10days 705950
Total Cash 34 M Next Fiscal Year End 1 B Revenue Per Share 3.22
Held Percent Insiders 0.0193 Ebitda Margins -19.06 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 3
Regular Market Previous Close 27.06 Target Low Price 27.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 24.16 Open 27.30 Free Cashflow 10 M
State WA Dividend Yield 0.00 % Return On Assets -0.0597
Time Zone Short Name EST Board Risk 8 Trailing Eps -1.11
Day Low 26.94 Address1 3303 Monte Villa Parkway Shares Outstanding 46 M
Compensation Risk 6 Price Hint 2 Target High Price 32.00
Website https://www.biolifesolutions.com 52 Week Change 1.20 Average Volume 386821
Forward Eps -0.2800 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 162.00 % Last Split Factor 1:14 Regular Market Day High 27.80
Is_sp_500 False Profit Margins -31.32 % Debt To Equity 12.06
Fifty Two Week High 28.88 Day High 27.80 Shares Short 2 M
Regular Market Open 27.30 Industry Key medical-instruments-supplies Earnings Growth 0.00 %
Enterprise To Revenue 8.61 Revenue Growth 29.70 % Shares Percent Shares Out 0.0579
Operating Cashflow 9 M Currency USD Time Zone Full Name America/New_York
Market Cap 1 B Is_nasdaq_100 False Zip 98021
Quote Type EQUITY Industry Medical Instruments & Supplies Long Name BioLife Solutions, Inc.
Overall Risk 6 Regular Market Day Low 26.94 Held Percent Institutions 0.9956
Current Price 27.16 Address2 Suite 310 Enterprise To Ebitda -45.17
Financial Currency USD Current Ratio 2.78 Gross Margins 37.53 %
Industry Disp Medical Instruments & Supplies Number Of Analyst Opinions 10 Country United States
Float Shares 36 M Two Hundred Day Average 21.45 Governance Epoch Date 1 B
Enterprise Value 1 B Price To Sales Trailing12 Months 8.57 Forward PE -502.96
Regular Market Volume 283255 Ebitda -28005000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.

It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services.

It markets and sells its products directly, as well as through third party distributors.

The company was incorporated in 1987 and is headquartered in Bothell, Washington.